Skip to main content

Management and Treatment of Pediatric Asthma: Update

Buy Article:

$39.50 plus tax (Refund Policy)


Much of what we know about the pathogenesis and treatment of asthma has been learned from adult studies. Recently, a dramatic shift toward the pediatric age group has occurred in both of these areas. Such studies in children have overall supported similarities with the adult population with regard to pathogenesis (airway inflammation) and treatment (anti-inflammatory controller medications). However, the onset of asthma symptoms in less than 5 years is 80% of the time, yet controller medications approved for children under 4 years of age have generally not been available. This treatment gap was recently filled by the FDA approval of two important asthma controller medications. This review will focus on the use of leukotriene receptor antagonists and inhaled corticosteroids, which were recently approved for use in asthmatic children under 4 years of age.

Document Type: Research Article


Publication date: March 1, 2001

More about this publication?
  • Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.

    The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.

    Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.

    Articles marked "F" offer free full text for personal noncommercial use only.

    The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Information for Advertisers
  • Reprint Requests
  • Ingenta Connect is not responsible for the content or availability of external websites

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Partial Open Access Content
Partial Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more